approximately significantP ≤ 0.01
Similarly, prognostic risk factors such as AFP, PT and tumor volume were approximately significant, with higher AIDRS correlating with increased risk ( P ≤ 0.01 ) ( Figures 8F–H ).
Similarly, prognostic risk factors such as AFP, PT and tumor volume were approximately significant, with higher AIDRS correlating with increased risk ( P ≤ 0.01 ) ( Figures 8F–H ).
In summary, it is hypothesized that high TMB and high TP53 mutations may be significant driving factors leading to substantial differences in molecular characteristics and clinical outcomes between CS1 and CS2.